Pharma Archives - Page 5 of 68 - Life Sciences Times

Firefly Health Becomes First National Primary Care Provider to Earn NCQA Virtual Care Accreditation

June 4, 2025

Amylyx Pharmaceuticals Earns FDA Fast Track Status for ALS Drug Candidate AMX0114

June 3, 2025

bluebird bio Acquired by Carlyle and SK Capital, Eyes Rapid Expansion Under New Leadership

June 2, 2025

THIS WEEK'S STORIES

Ontario Brain Injury Association Warns of Hidden Dangers in Surviving Opioid Overdoses

June 4, 2025

Scholar Rock Names Rebecca McLeod Chief Brand Officer and U.S. General Manager to Lead Apitegromab Launch

June 2, 2025

Enveric Biosciences Secures U.S. Patent for Novel Melatonin Receptor-Targeting Compounds

June 3, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Pharma

CinDome Pharma Begins Phase 2 Trial of Deudomperidone for Idiopathic Gastroparesis

Pheast Therapeutics Earns FDA Fast Track Designation for Experimental Ovarian Cancer Therapy PHST001

Rion Aesthetics Backs First U.S. Clinical Trial Testing Dermal Injections of PEP™ Exosomes

European Commission Approves ADCETRIS Combination Therapy for Advanced Hodgkin Lymphoma

Amylyx Pharmaceuticals Earns FDA Fast Track Status for ALS Drug Candidate AMX0114

Most Read

Ontario Brain Injury Association Warns of Hidden Dangers in Surviving Opioid Overdoses

Canid Raises $10 Million to Modernize Pediatric Vaccine Management and Reduce Burden on Independent Practices

Cyberattacks Disrupt Patient Care in Nearly 1 in 5 Healthcare Organizations, Omega Systems Report Finds

Gore Launches 0.5 mL Silicone-Free Plunger for Ophthalmic Pre-Filled Syringes

EDITOR PICKS

Firefly Health Becomes First National Primary Care Provider to Earn NCQA Virtual Care Accreditation

Amylyx Pharmaceuticals Earns FDA Fast Track Status for ALS Drug Candidate AMX0114

bluebird bio Acquired by Carlyle and SK Capital, Eyes Rapid Expansion Under New Leadership

THIS WEEK'S STORIES

Ontario Brain Injury Association Warns of Hidden Dangers in Surviving Opioid Overdoses

Scholar Rock Names Rebecca McLeod Chief Brand Officer and U.S. General Manager to Lead Apitegromab Launch

Enveric Biosciences Secures U.S. Patent for Novel Melatonin Receptor-Targeting Compounds

POPULAR CATEGORY

ABOUT US

FOLLOW US